Nocardiosis at the turn of the century

Medicine

Volumn 88, Issue 4, 2009, Pages 250-261

  Minero, Maricela Valerio ^a   Marín, Mercedes ^a,b   Cercenado, Emilia ^a,b   Rabadán, Pablo Martín ^a   Bouza, Emilio ^a,b   Muñoz, Patricia ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CORTICOSTEROID; COTRIMOXAZOLE; IMIPENEM; LINEZOLID; MEROPENEM; MINOCYCLINE; PREDNISONE; RIBOSOME RNA; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOIMMUNE DISEASE; BACTERIUM ISOLATION; BROTH DILUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COUGHING; FEMALE; FEVER; GENOTYPE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERVENTILATION; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; MORBIDITY; MORTALITY; NEOPLASM; NOCARDIA ASTEROIDES; NOCARDIACEAE; NOCARDIOSIS; ORGAN TRANSPLANTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SHOCK; SKIN DEFECT; MICROBIOLOGY; MIDDLE AGED; NOCARDIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFECTIVE AGENTS; AUTOIMMUNE DISEASES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; NOCARDIA; NOCARDIA INFECTIONS; ORGAN TRANSPLANTATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 67651091667     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181afa1c8     Document Type: Article

References (76)

1. Arduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993;16:505-512.
2. Bani-Sadr F, Hamidou M, Raffi F, Chamoux C, Caillon J, Freland C. [Clinical and bacteriological aspects of nocardiasis. 9 cases]. Presse Med. 1995;24:1062-1066.
3. Beaman BL, Burnside J, Edwards B, Causey W. Nocardial infections in the United States, 1972-1974. J Infect Dis. 1976;134:286-289.
4. Bogaard HJ, Erkelens GW, Faber WR, de Vries PJ. [Cutaneous nocardiosis as an opportunistic infection]. Ned Tijdschr Geneeskd. 2004;148:533-536.
5. Boiron P, Provost F, Chevrier G, Dupont B. Review of nocardial infections in France 1987 to 1990. Eur J Clin Microbiol Infect Dis. 1992;11:709-714.
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
7. Bouza E, Guinea J, Pelaez T, Perez-Molina J, Alcala L, Munoz P. Workload due to Aspergillus firmigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol. 2005;43:2075-2079.
8. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19:259-282.
9. Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother. 2001;45:1295-1297.
10. Brown BA, Lopes JO, Wilson RW, Costa JM, de Vargas AC, Alves SH, Klock C, Onyi GO, Wallace RJ Jr. Disseminated Nocardia pseudobrasiliensis infection in a patient with AIDS in Brazil. Clin Infect Dis. 1999;28:144-145.
11. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782-800.
12. Castro JG, Espinoza L. Nocardia species infections in a large county hospital in Miami: 6 years experience. J Infect. 2007;54:358-361.
13. Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2007;51:1102-1104.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
15. Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. Clin Infect Dis. 1996;23:1012-1019.
16. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved standard. CLSI document M24-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2003.
17. Cloud JL, Conville PS, Croft A, Harmsen D, Witebsky FG, Carroll KC. Evaluation of partial 16S ribosomal DNA sequencing for identification of Nocardia species by using the MicroSeq 500 system with an expanded database. J Clin Microbiol. 2004;42:578-584.
18. Conville PS, Witebsky FG. Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica. J Clin Microbiol. 2007;45:2257-2259.
19. Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM. Nocardia infection in chronic granulomatous disease. Clin Infect Dis. 2002;35:390-394.
20. Farina C, Boiron P, Ferrari I, Provost F, Goglio A. Report of human nocardiosis in Italy between 1993 and 1997. Eur J Epidemiol. 2001;17:1019-1022.
21. Farina C, Boiron P, Goglio A, Provost F Human nocardiosis in northern Italy from 1982 to 1992. Northern Italy Collaborative Group on Nocardiosis. Scand J Infect Dis. 1995;27:23-27.
22. Ferrer A, Llorenc V, Codina G, de Gracia-Roldan J. [Nocardiosis and bronchiectasis. An uncommon association?]. Enferm Infecc Microbiol Clin. 2005;23:62-66.
23. Forbes GM, Harvey FA, Philpott-Howard JN, O'Grady JG, Jensen RD, Sahathevan M, Casewell MW, Williams R. Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy. J Infect. 1990;20:11-19.
24. Frazier AR, Rosenow EC 3rd, Roberts GD. Nocardiosis. A review of 25 cases occurring during 24 months. Mayo Clin Proc. 1975;50:657-663.
25. Freites V, Sumoza A, Bisotti R, Mujica M, Cabrera A, Costa M, Anguilo R, Rolston K. Subcutaneous Nocardia asteroides abscess in a bone marrow transplant recipient. Bone Marrow Transplant. 1995;15:135-136.
26. Georghiou PR, Blacklock ZM. Infection with Nocardia species in Queensland. A review of 102 clinical isolates. Med JAust. 1992;156:692-697.
27. Goldstein FW, Hautefort B, Acar JF Amikacin-containing regimens for treatment of nocardiosis in immunocompromised patients. Eur J Clin Microbiol. 1987;6:198-200.
28. Gombert ME. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin. Antimicrob Agents Chemother. 1982;21:1011-1012.
29. Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983;24:810-811.
30. Gombert ME, Aulicino TM, duBouchet L, Berkowitz LR. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams. Antimicrob Agents Chemother. 1987;31:2013-2014.
31. Hall WA, Martinez AJ, Dummer JS, Griffith BP, Hardesty RL, Bahnson HT, Lunsford LD. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989;46:173-177.
32. Hizel K, Caglar K, Cabadak H, Kulah C. Pulmonary nocardiosis in a non-Hodgkin's lymphoma patient. Infection. 2002;30:243-245.
33. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987;106:209-216.
34. Hui CH, Au VW, Rowland K, Slavotinek JP, Gordon DL. Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis. Respir Med. 2003;97:709-717.
35. Husain S, McCurry K, Dauber J, Singh N, Kusne S. Nocardia infection in lung transplant recipients. J Heart Lung Transplant. 2002;21:354-359.
36. Jones N, Khoosal M, Louw M, Karstaedt A. Nocardial infection as a complication of HIV in South Africa. J Infect. 2000;41:232-239.
37. Kiska DL, Hicks K, Pettit DJ. Identification of medically relevant Nocardia species with an abbreviated battery of tests. J Clin Microbiol. 2002;40:1346-1351.
38. Lederman ER, Crum NF A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore). 2004;83:300-313.
39. Lucas SB, Hounnou A, Peacock C, Beaumel A, Kadio A, De Cock KM. Nocardiosis in HIV-positive patients: an autopsy study in West Africa. Tuber Lung Dis. 1994;75:301-307.
40. Mandell G, Bennett J, Dolin R. Principles and Practice of Infectious Diseases. Vol. 2. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005:3661.
41. Mari B, Monton C, Mariscal D, Lujan M, Sala M, Domingo C. Pulmonary nocardiosis: clinical experience in ten cases. Respiration. 2001;68:382-388.
42. Martinez Tomas R, Menendez Villanueva R, Reyes Calzada S, Santos Durantez M, Valles Tarazona JM, Modesto Alapont M, Gobernado Serrano M. Pulmonary nocardiosis: risk factors and outcomes. Respirology 2007;12:394-400.
43. Matulionyte R, Rohner P, Uckay I, Lew D, Garbino J. Secular trends of Nocardia infection over 15 years in a tertiary care hospital. J Clin Pathol. 2004;57:807-812.
44. McCabe W, Jackson G. Gram-negative bacteremia, I: etiology and ecology. Arch Intern Med. 1962;110:847-855.
45. Menendez R, Cordero PJ, Santos M, Gobernado M, Marco V Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur Respir J. 1997;10:1542-1546.
46. Mootsikapun P, Intarapoka B, Liawnoraset W. Nocardiosis in Srinagarind Hospital, Thailand: review of 70 cases from 1996-2001. Int J Infect Dis. 2005;9:154-158.
47. Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birmingham MC, Schentag JJ, Gimbel JF, Apodaca A, Schwartz MA, Rakita RM, Wallace RJ Jr. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis. 2003;36:313-318.
48. Munoz J, Mirelis B, Aragon LM, Gutierrez N, Sanchez F, Espanol M, Esparcia O, Gurgui M, Domingo P, Coll P. Clinical and microbiological features of nocardiosis 1997-2003. J Med Microbiol. 2007;56:545-550.
49. Munoz P, Munoz RM, Palomo J, Rodriguez-Creixems M, Munoz R, Bouza E. Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. Medicine (Baltimore). 1997;76:415-422.
50. Patel JB, Wallace RJ Jr, Brown-Elliott BA, Taylor T, Imperatrice C, Leonard DG, Wilson RW, Mann L, Jost KC, Nachamkin I. Sequence-based identification of aerobic actinomycetes. J Clin Microbiol. 2004;42:2530-2540.
51. Patel R, Paya CV Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997;10:86-124.
52. Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44:1307-1314.
53. Peraira JR, Segovia J, Fuentes R, Jimenez-Mazuecos J, Arroyo R, Fuertes B, Mendaza P, Pulpon LA. Pulmonary nocardiosis in heart transplant recipients: treatment and outcome. Transplant Proc. 2003;35:2006-2008.
54. Perschak H, Gubler J, Speich R, Russi E. Pulmonary nocardiosis concurrent with Pneumocystis carinii pneumonia in two patients undergoing immunosuppressive therapy. J Infect. 1991;23: 183-185.
55. Pintado V, Gomez-Mampaso E, Cobo J, Quereda C, Meseguer MA, Fortun J, Navas E, Moreno S. Nocardial infection in patients infected with the human immunodeficiency virus. Clin Microbiol Infect. 2003;9:716-720.
56. Poonyagariyagorn HK, Gershman A, Avery R, Minai O, Blazey H, Asamoto K, Alster J, Murthy S, Mehta A, Pettersson G, Mason DP, Budev M. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis. 2008;10:403-408.
57. Queipo-Zaragoza JA, Broseta-Rico E, Alapont-Alacreu JM, Santos-Durantez M, Sanchez-Plumed J, Jimenez-Cruz JF. Nocardial infection in immunosuppressed kidney transplant recipients. Scand J Urol Nephrol. 2004;38:168-173.
58. Raich RA, Casey F, Hall WH. Pulmonary and cutaneous nocardiosis. The significance of the laboratory isolation of Nocardia. Am Rev Respir Dis. 1961;83:505-509.
59. Roberts SA, Franklin JC, Mijch A, Spelman D. Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989-1998. Clin Infect Dis. 2000;31:968-972.
60. Rodriguez-Nava V, Couble A, Devulder G, Flandrois JP, Boiron P, Laurent F Use of PCR-restriction enzyme pattern analysis and sequencing database forhsp65 gene-based identification of Nocardia species. J Clin Microbiol. 2006;44:536-546.
61. Rosett W, Hodges GR. Recent experiences with nocardial infections. Am J Med Sci. 1978;276:279-285.
62. Roth A, Andrees S, Kroppenstedt RM, Harmsen D, Mauch H. Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons. J Clin Microbiol. 2003;41:851-856.
63. Santamaria Saber LT, Figueiredo JF, Santos SB, Levy CE, Reis MA, Ferraz AS. Nocardia infection in renal transplant recipient: diagnostic and therapeutic considerations. Rev Inst Med Trop Sao Paulo. 1993;35:417-421.
64. Scopetti F, Iona E, Fattorini L, Goglio A, Franceschini N, Amicosante G, Orefici G. Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients. J Chemother. 1994;6:29-34.
65. Shearer C, Chandrasekar PH. Pulmonary nocardiosis in a patient with a bone marrow transplant. Bone Marrow Transplantation Team. Bone Marrow Transplant. 1995;15:479-481.
66. Simpson GL, Stinson EB, Egger MJ, Remington JS. Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev Infect Dis. 1981;3:492-507.
67. Steingrube VA, Brown BA, Gibson JL, Wilson RW, Brown J, Blacklock Z, Jost K, Locke S, Ulrich RF, Wallace RJ Jr. DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol. 1995;33:3096-3101.
68. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175-178.
69. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vazquez G. Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis. 2000;19:205-212.
70. van Burik JA, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, Bowden RA. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis. 1997;24:1154-1160.
71. Vigil K, Pasumarthy A, Johnson L, Sheppard T, El-Ghoroury M, del Busto R. Nocardiosis in renal transplant patients: role of current immunosuppressant agents. Infect Dis Clin Pract. 2007;15:171-173.
72. Wallace RJ, Brown BA, Brown JM, McNeil M. Taxonomy of Nocardia species. Clin Infect Dis. 1994;18:476-477.
73. Wallace RJ Jr, Septimus EJ, Musher DM, Martin RR. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977;135:568-576.
74. Wallace RJ Jr, Septimus EJ, Williams TW Jr, Conklin RH, Satterwhite TK, Bushby MB, Hollowell DC. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982;4:315-325.
75. Wiesmayr S, Stelzmueller I, Tabarelli W, Bargehr D, Graziadei I, Freund M, Ladurner R, Steurer W, Geltner C, Mark W, Margreiter R, Bonatti H. Nocardiosis following solid organ transplantation: a single-centre experience. Transpl Int. 2005;18:1048-1053.
76. Wilson JP, Turner HR, Kirchner KA, Chapman SW Nocardial infections in renal transplant recipients. Medicine (Baltimore). 1989;68:38-57.